The Food and Drug Administration (FDA) has recently approved an expanded form for Synjardy, a drug produced by Boehringer Ingelheim and Eli Lilly. Also known as empagliflozin/metformin hydrochloride, Synardy is now approved for use as an adjunctive treatment. When used …
The post Diabetes Health in The News: FDA Expands Coverage for Lilly, Boehringer Diabetes Drug appeared first on Diabetes Health.
from Diabetes Health http://ift.tt/2bOJiOr
from roundsroundup http://ift.tt/2cvk8dv
from Rounds Roundup http://ift.tt/2bXKDWA
No comments:
Post a Comment